News
Company Publishes Overview of Its Biological Source Platform
product development
Better Cann Pharmaceutical published an overview of its biological source platform, describing long-term selection and stabilization of proprietary genetics developed since 2009.
The platform underpins the company’s objective of reproducible, standardized therapeutic source materials.
Media contact: Better Cann Pharmaceutical Communications